Cargando…
Transcriptome Profiling of Neovascularized Corneas Reveals miR-204 as a Multi-target Biotherapy Deliverable by rAAVs
Corneal neovascularization (NV) is the major sight-threatening pathology caused by angiogenic stimuli. Current drugs that directly target pro-angiogenic factors to inhibit or reverse the disease require multiple rounds of administration and have limited efficacies. Here, we identify potential anti-a...
Autores principales: | Lu, Yi, Tai, Phillip W.L., Ai, Jianzhong, Gessler, Dominic J., Su, Qin, Yao, Xieyi, Zheng, Qiang, Zamore, Phillip D., Xu, Xun, Gao, Guangping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862543/ https://www.ncbi.nlm.nih.gov/pubmed/29499946 http://dx.doi.org/10.1016/j.omtn.2017.12.019 |
Ejemplares similares
-
rAAV-delivered PTEN therapeutics for prostate cancer
por: Ai, Jianzhong, et al.
Publicado: (2021) -
Vectored Immunotherapeutics for Infectious Diseases: Can rAAVs Be The Game Changers for Fighting Transmissible Pathogens?
por: Zhan, Wei, et al.
Publicado: (2021) -
Long-term, efficient inhibition of microRNA function in mice using rAAV vectors
por: Xie, Jun, et al.
Publicado: (2012) -
Durability of transgene expression after rAAV gene therapy
por: Muhuri, Manish, et al.
Publicado: (2022) -
Robust Long-term Transduction of Common Marmoset Neuromuscular Tissue With rAAV1 and rAAV9
por: Okada, Hironori, et al.
Publicado: (2013)